The U.S. government has created several, overlapping, lists of viruses, bacteria, toxins, and diseases that could threaten the health and safety of the public, animals, and plants. Although the contents of the different lists are similar, the purpose of the three lists, described below, vary.
The viruses, bacteria, and toxins on the Select Agents List are federally restricted through regulation of their possession, use, and transfer. Two agencies, the Centers for Disease Control and Prevention (CDC) and the Animal and Plant Health Inspection Service (APHIS), which protect and promote the health of humans and animals and plants, spearhead the Select Agent Program for the Department of Health and Human Services (HHS) and the Department of Agriculture (USDA), respectively. The agencies ensure that restrictions, such as registration with the CDC or APHIS of entities possessing the agents and completion of a Federal Bureau of Investigation security risk assessment form, are in place. They also determine what is categorized as a select agent by using the following criteria:
- The effect that exposure to the agent or toxin has on human, animal, or plant health, or on animal or plant products;
- How the agent or toxin transfers to humans, animals, or plants and how contagious, virulent, and toxic it is;
- The effectiveness and supply of treatments and vaccines for any resulting disease; and
- Any other criteria deemed critical such as susceptibility of specific age groups.
The CDC has another list, its Bioterrorism Diseases/Agents List, which is not associated with any Congressional mandate or federal regulations. It simply groups diseases, viruses, bacteria, and toxins that target humans into three different categories: A, B, and C. Category A agents present a great threat to public health and national security and:
- Have high rates of transmission and/or fatalities;
- Can have a great impact on public health since few health professionals have experience with the agents; and
- Can potentially cause social disruption or a panicked public response.
Category B agents:
- Spread with moderate ease;
- Cause moderate rates of disease with low death rates; and
- Necessitate specific lab capabilites and disease monitoring by the CDC.
Category C agents, which include emerging viruses, bacteria, and toxins, could be modified for dissemination due to:
- Availability;
- Easy production and spreading; and
- Potentially high infection and/or death rates.
The National Institute of Allergy and Infectious Diseases (NIAID) is responsible for the Category A, B, and C Priority Pathogens List, a third lists of viruses, bacteria, and toxins. Although its categorical structure is modeled after the CDC's Bioterrorism Diseases/Agents List, its purpose is to prioritize the Institute's biodefense research and funding on specific viruses, bacteria, and toxins.
HHS Select Agents and Toxins (PDF) |
Abrin |
Cercopithecine herpesvirus 1 (Herpes B virus) |
Coccidioides posadasii |
Conotoxins |
Crimean-Congo hemorrhagic fever virus |
Diacetoxyscirpenol |
Ebola virus |
Lassa fever virus |
Marburg virus |
Monkeypox virus |
Reconstructed replication competent forms of the 1918 pandemic influenza virus containing any portion of the coding regions of all eight gene segments (Reconstructed 1918 Influenza virus) |
Ricin |
Rickettsia prowazekii |
Rickettsia rickettsii |
Saxitoxin |
Shiga-like ribosome inactivating proteins |
South American Hemorrhagic Fever viruses |
Tetrodotoxin |
Flexal |
Guanarito |
Junin |
Machupo |
Sabia |
|
Tick-borne encephalitis complex (flavi) viruses |
Variola major virus (Smallpox virus) and
Variola minor virus (Alastrim) |
Central European Tick- borne encephalitis |
Far Eastern Tick- borne encephalitis |
Kyasanur Forest disease |
Omsk Hemorrhagic Fever |
Russian Spring and Summer encephalitis |
Yersinia pestis |
USDA Livestock Select Agents and Toxins (PDF) |
African horse sickness virus |
African swine fever virus |
Akabane virus |
Avian influenza virus (highly pathogenic) |
Bluetongue virus (Exotic) |
Bovine spongiform encephalopathy agent |
Camel pox virus |
Classical swine fever virus |
Cowdria ruminantium (Heartwater) |
Foot-and-mouth disease virus |
Goat pox virus |
Japanese encephalitis virus |
Lumpy skin disease virus |
Malignant catarrhal fever virus (Alcelaphine herpesvirus type 1) |
Menangle virus |
Mycoplasma capricolum/ M.F38/M. mycoides Capri
(contagious bovine pleuropneumonia) |
Mycoplasma mycoides mycoides
(contagious bovine pleuropneumonia) |
Newcastle disease virus (velogenic) |
Peste des petits ruminants virus |
Rinderpest virus |
Sheep pox virus |
Swine vesicular disease virus |
Vesicular stomatitis virus (Exotic) |
USDA Plant Select Agents and Toxins (PDF) |
Candidatus Liberobacter africanus |
Candidatus Liberobacter asiaticus |
Peronosclerospora philippinensis |
Ralstonia solanacearum race 3, biovar 2 |
Schlerophthora rayssiae var zeae |
Synchytrium endobioticum |
Xanthomonas oryzae pv. oryzicola |
Xylella fastidiosa (citrus variegated chlorosis strain) |
Overlapping (Human and Livestock) Select Agents and Toxins (PDF) |
Bacillus anthracis |
Botulinum neurotoxins |
Botulinum neurotoxin producing species of Clostridium |
Brucella abortus |
Brucella melitensis |
Brucella suis |
Burkholderia mallei (formerly Pseudomonas mallei) |
Burkholderia pseudomallei (formerly Pseudomonas pseudomallei) |
Clostridium perfringens epsilon toxin |
Coccidioides immitis |
Coxiella burnetii |
Eastern Equine Encephalitis virus |
Francisella tularensis |
Hendra virus |
Nipah virus |
Rift Valley fever virus |
Shigatoxin |
Staphylococcal enterotoxins |
T-2 toxin |
Venezuelan Equine Encephalitis virus |
CDC Bioterrorism Diseases/Agents (PDF) |
Category A Diseases/Agents |
Anthrax (Bacillus anthracis) |
Botulism (Clostridium botulinum toxin) |
Plague (Yersinia pestis) |
Smallpox (variola major) |
Tularemia (Francisella tularensis) |
Viral hemorrhagic fevers (filoviruses [e.g., Ebola, Marburg] and arenaviruses [e.g., Lassa, Machupo]) |
Category B Diseases/Agents |
Brucellosis (Brucella species) |
Epsilon toxin of Clostridium perfringens |
Food safety threats (e.g., Salmonella species, Escherichia coli O157:H7, Shigella) |
Glanders (Burkholderia mallei) |
Melioidosis (Burkholderia pseudomallei) |
Psittacosis (Chlamydia psittaci) |
Q fever (Coxiella burnetii) |
Ricin toxin from Ricinus communis (castor beans) |
Staphylococcal enterotoxin B |
Typhus fever (Rickettsia prowazekii) |
Viral encephalitis (alphaviruses [e.g., Venezuelan equine encephalitis, eastern equine encephalitis, western equine encephalitis]) |
Water safety threats (e.g., Vibrio cholerae, Cryptosporidium parvum) |
Category C Diseases/Agents |
Emerging infectious diseases such as Nipah virus and hantavirus |
NIAID Category A, B, and C Priority Pathogens (PDF) |
Category A |
Bacillus anthracis (anthrax) |
Clostridium botulinum |
Yersinia pestis |
Variola major (smallpox) and other pox viruses |
Francisella tularensis (tularemia) |
Viral hemorrhagic fevers |
Arenaviruses
LCM, Junin virus, Machupo
virus, Guanarito virus
Lassa Fever |
Bunyaviruses
Hantaviruses
Rift Valley Fever |
Filoviruses
Dengue |
Flaviruses
Ebola
Marburg |
Category B |
Burkholderia pseudomallei |
Coxiella burnetii (Q Fever) |
Brucella species (brucellosis) |
Burkholderia mallei (glanders) |
Ricin toxin from (Ricinus communis) |
Epsilon toxin of Clostridium perfringens |
Staphylococcus enterotoxin B |
Typhus fever (Rickettsia prowazekii) |
Chlamydia psittaci (psittacosis) |
|
Food and Waterborne Pathogens |
Bacteria
Diarrheagenic E.coli
Pathogenic Vibrios
Shigella species
Salmonella
Listeria monocytogenes
Campylobacter jejuni
Yersinia enterocolitica
| Viruses
Caliciviruses
Hepatitis A |
Protozoa
Cryptosporidium parvum
Cyclospora cayetanensis
Giardia lamblia
Entamoeba histolytica
Toxoplasma
Microsporidia |
Additional viral encephalitides |
West Nile Virus
EEE |
LaCrosse
WEE |
California encephalitis
Japanese encephalitis Virus |
VEE
Kyasanur forest Virus |
Category C |
Emerging infectious diseases such as Nipah virus and additional hantavirus |
Tickborne hemorrhagic fever viruses
Crimean-Congo Hemorrhagic fever
virus |
Tickborne encephalitis viruses |
Yellow fever |
Multi-drug resistant TB |
Influenza |
Other Rickettsias |
Rabies |
Severe acute respiratory syndrome-associated
coronavirus (SARS-CoV) |
Prions |
Chikungunya virus |
Antimicrobial resistance, as related to engineered threats |
Innate immunity, defined as the study of non-adaptive immune mechanisms that recognize, and respond to, microorganisms, microbial products, and antigens |
Antimicrobial resistance excluding
research on sexually transmitted
organisms such as: |
Bacterial vaginosis
Hemophilus ducreyi
Human immunodeficiency virus Trichomonas vaginalis |
Chlamydia trachomatis
Hepatitis B virus Human papillomavirus |
Cytomegalovirus
Hepatitis C virus
Neisseria gonorrhea |
Granuloma inguinale
Herpes Simplex virus
Treponema pallidum |
Select Agent Rules
APHIS-CDC Select Agent Security Documents
Related Reports
- NIAID Strategic Plan for Biodefense Research, 2007 Update
- NIAID Biodefense Research Agenda for CDC Catagory A Agents, Overview of Progress Report, 2006
- NIAID Biodefense Research Agenda for CDC Catagory A Agents, Progress Report, 2006
- NIAID Biodefense Research Agenda for Category B and C Prioirty Pathogens, Progress Report, June 2004
- NIAID Biodefense Research Agenda for CDC Category A Agents, Progress Report, August 2003
- NIAID Biodefense Research Agenda for CDC Category B and C Priority Pathogens, January 2003
- NIAID Biodefense Research Agenda for CDC Category A Agents, February 2002
- NIAID Strategic Plan for Biodefense Research, February 2002
Related Sites
|